The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

G.H. Gislason, J.N. Rasmussen, S.Z. Abildstrom, S. Rasmussen, T.K. Schramm, F. Folke, M.L. Hansen, Lars Valeur Køber, M. Madsen, C. Torp-Pedersen

OriginalsprogEngelsk
TidsskriftCirculation
Udgave nummer16
Sider (fra-til)3271-
ISSN0009-7322
StatusUdgivet - 2007
BegivenhedThe risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure -
Varighed: 29 nov. 2010 → …

Konference

KonferenceThe risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure
Periode29/11/2010 → …

Citationsformater